- 专利标题: Recombinant C140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
-
申请号: US476976申请日: 1995-06-07
-
公开(公告)号: US5874400A公开(公告)日: 1999-02-23
- 发明人: Johan Sundelin , Robert M. Scarborough
- 申请人: Johan Sundelin , Robert M. Scarborough
- 申请人地址: CA South San Francisco
- 专利权人: COR Therapeutics
- 当前专利权人: COR Therapeutics
- 当前专利权人地址: CA South San Francisco
- 主分类号: A61K38/00
- IPC分类号: A61K38/00 ; A61K48/00 ; C07K7/06 ; C07K7/08 ; C07K14/72 ; C12N15/12 ; A61K39/395 ; C07K16/28 ; G01N33/53
摘要:
Nucleic acid molecules encoding the C140 cell surface receptor have been cloned and sequenced. The availability of C140 receptor DNA permits the recombinant production of the C140 receptor which can be produced on the surface of a cell, including an oocyte. The nucleic acid molecules are useful in an assay for detecting a substance which affects C140 receptor activity, either receptor agonists or antagonists. Further, the elucidation of the structure of the C140 receptor permits the design of agonist and antagonist compounds which are useful in such assays. The availability of the C140 receptor also permits production of antibodies specifically immunoreactive with one or more antigenic epitopes of the C140 receptor.
公开/授权文献
- US5140816A Internal combustion engine turbo charger 公开/授权日:1992-08-25
信息查询
IPC分类: